基于机器学习的虚拟查和分子模拟方法确定了癌症治疗的新型潜在抑制剂
Muhammad Shahab1, Guojun Zheng1, Abbas Khan2
1State Key Laboratories of Chemical Resources Engineering, Beijing University of Chemical Technology, Beijing 100029, China.
Biomedicines
|August 26, 2023
概括
机器学习确定了针对癌症治疗的循环素依赖激酶2 (CDK2) 的新型候选药物. 三种有前途的化合物显示出增强的稳定性和紧性,为开发选择性CDK2抑制剂提供了新的途径.
科学领域:
- 在瘤学瘤学.
- 计算化学计算化学
- 药物发现 药物发现 药物发现
背景情况:
- 循环素依赖性激酶2 (CDK2) 是癌症治疗的关键标,但选择性抑制剂缺乏.
- 向CDK2为特定瘤类型提供了潜在的好处,推动了药物开发工作.
研究的目的:
- 使用机器学习来识别CDK2.2的新型小分子抑制剂.
- 发现和验证潜在的候选药物,以高的准确性和有效性对抗CDK2.
主要方法:
- 利用机器学习模型 (k-NN,SVM,RF,GNB) 进行化合物的虚拟选.
- 对模型准确性进行了10倍交叉验证,并分析了数据库.
- 应用分子对接和分子动力学 (MD) 模拟来评估选定的化合物.
主要成果:
- 机器学习模型准确地预测了活性和非活性CDK2抑制剂.
- 确定了25种化合物,准确率为98%作为潜在的CDK2抑制剂.
- 通过MD模拟,与参考药物相比,三种选择的化合物表现出优越的稳定性和紧性.
结论:
- 基于机器学习的药物设计有效地确定了有前途的CDK2抑制剂候选者.
- 高斯的天真贝叶斯模型在预测抑制剂活性方面表现出卓越的表现.
- 这项研究为提炼化合物作为潜在的CDK2向癌症疗法提供了基础.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Drug Discovery: Overview
8.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.0K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


